This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Antiviral Immunoglobulin Market

Market Insights on Antiviral Immunoglobulin covering sales outlook, demand forecast & up-to-date key trends

Antiviral Immunoglobulin Market by Administration, Distribution Channel & Region | Forecast 2022 to 2032

Antiviral Immunoglobulin Market Overview

The global antiviral immunoglobulin market was valued at around US$ 3,401.18 Million at the end of 2021. The market is projected to register a 6.3% CAGR and top a valuation of US$ 6,660.33 Million by 2032.

The main factors propelling the expansion of the antiviral immunoglobulin market is increasing incidence of bleeding disorders such as hemophilia B (factor IX deficiency), hemophilia A (factor VIII deficiency), and von Willebrand disease.

Large Y-shaped proteins, known as antibodies or immunoglobulins, are created by B cells. These are the glycoprotein molecules that plasma cells make in reaction to the body being invaded by external agents like bacteria and viruses.

Lower respiratory tract infections, HCV re-infection prevention, disorders brought on by the vaccinia virus, rare adverse reactions to smallpox immunisation, and severe varicella-zoster infection prevention are all treated with antiviral immunoglobulin.

A class of medications known as antiviral pharmaceuticals is used to treat viral infections only, not bacterial ones. Unlike antibiotics, which kill their target bacteria, antivirals work to suppress their targets.

Attributes

Details

Antiviral Immunoglobulin Market Value in 2021

US$ 3,401.18 Million

Antiviral Immunoglobulin Market Value in 2032

US$ 6,660.33 Million

Antiviral Immunoglobulin Market CAGR (2022 to 2032)

6.3%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Major Drivers Boosting the Demand for Antiviral Immunoglobulin Market?

The pharmaceutical industry's antiviral immunoglobulin market is primarily driven by a few significant variables, including the usage of treatments for neurological disorders and primary immunodeficiency, rising rates of bleeding disorders, an ageing population, and longer life expectancies.

In addition to this, the market for antiviral immunoglobulins is expanding significantly as a result of rising healthcare costs in emerging nations. The market for antiviral immunoglobulins is greatly boosted by their usage for novel disease indications including myasthenia gravis.

The market for antiviral immunoglobulins is driven by the novel drugs that have been approved by numerous regulatory bodies around the world.

Which Region Shows Strong Growth Potential in the Antiviral Immunoglobulin Market?

The antiviral immunoglobulin market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America dominates the market for antiviral immunoglobulins, followed by Europe. The rules set by the USA Food and Drug Administration influence the North American market. The FDA's recent approval of a single human immunoglobulin for subcutaneous usage has fuelled the market for antiviral immunoglobulin growth in North America.

The FDA in the USA has granted fast-track designation to a number of medications in order to streamline the drug development process and increase the availability of antiviral immunoglobulin medications. Additionally, the USA Food and Drug Administration grants approval for several medications under the IND protocol. The market for antiviral immunoglobulins in North America is projected to grow in the next years as a result of these laws and approvals.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Who are the Key Manufacturers in the Antiviral Immunoglobulin Market?

CSL Behring, AstraZeneca Plc, Cangene Corporation, Omrix Biopharmaceuticals, Inc, Bayer AG, Talecris Biotherapeutics, Inc, Biota Holdings Limited, Sanofi Pasteur SA, and Baxter International Inc.

Scope of Report

Report Attributes

Details

Growth Rate

CAGR of 6.3% 2022 to 2032

Base Year for Estimation

2021

Historical Data

2012 to 2021

Forecast Period

2022 to 2032

Qualitative Units

Revenue in USD Million, Volume in Units, and CAGR from 2022 to 2032

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segment Covered

  • Distribution Channel
  • Administration

Region Covered

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key Countries Profiled

  • USA
  • Canada
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Russia
  • China
  • Japan
  • South Korea
  • India
  • Malaysia
  • Indonesia
  • Thailand
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • North Africa
  • Turkey

Key Players

  • CSL Behring
  • AstraZeneca Plc
  • Cangene Corporation
  • Omrix Biopharmaceuticals, Inc
  • Bayer AG
  • Talecris Biotherapeutics, Inc
  • Biota Holdings Limited
  • Sanofi Pasteur SA
  • Baxter International Inc

Customization

Available Upon Request

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Key Segments Covered in the Antiviral Immunoglobulin Market Survey

By Administration:

  • Subcutaneous
  • Intramuscular Injections
  • Intravenous

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global antiviral immunoglobulin market is anticipated to register a CAGR of 6.3% during the forecast period.

CSL Behring, AstraZeneca Plc, Cangene Corporation, Omrix Biopharmaceuticals, Inc, Bayer AG, Talecris Biotherapeutics, Inc, Biota Holdings Limited, Sanofi Pasteur SA, and Baxter International Inc, among others are some prominent antiviral immunoglobulin market players.

Table of Content

NA

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

NA
Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

NA

Explore Healthcare Insights

View Reports
Google translate

Antiviral Immunoglobulin Market